Platelet-endothelial cell adhesion molecule-1-directed endothelial targeting of superoxide dismutase alleviates oxidative stress caused by either extracellular or intracellular superoxide

Journal of Pharmacology and Experimental Therapeutics

Volumn 323, Issue 2, 2007, Pages 450-457

  Shuvaev, Vladimir V ^a   Tliba, Samira ^a   Nakada, Marian ^b   Albelda, Steven M ^a   Muzykantov, Vladimir R ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CENTOCOR INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ARTICLE; CELL DEATH; CELL PROTECTION; CHEMICAL MODIFICATION; ENDOTHELIUM; ENZYME ACTIVITY; MOUSE; NECROSIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SYNTHESIS;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD31; BIOTINYLATION; CELLS, CULTURED; ENDOTHELIAL CELLS; HUMANS; HYPOXANTHINE; IMMUNOCONJUGATES; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE; SUPEROXIDES;

EID: 35548999702     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.107.127126     Document Type: Article

References (41)

1. Beckman JS, Minor RL Jr, White CW, Repine JE, Rosen GM, and Freeman BA (1988) Superoxide dismutase and catalase conjugated to polyethylene glycol increases endothelial enzyme activity and oxidant resistance. J Biol Chem 263: 6884-6892.
2. Bonaventura J and Gow A (2004) NO and superoxide: opposite ends of the seesaw in cardiac contractility. Proc Natl Acad Sci U S A 101:16403-16404.
3. Bonder CS, Knight D, Hernandez-Saavedra D, McCord JM, and Kubes P (2004) Chimeric SOD2/3 inhibits at the endothelial-neutrophil interface to limit vascular dysfunction in ischemia-reperfusion. Am J Physiol 287:G676-G684.
4. Cai H, Griendling KK, and Harrison DG (2003) The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol Sci 24:471-478.
5. Christofidou-Solomidou M and Muzykantov VR (2006) Antioxidant strategies in respiratory medicine. Treat Respir Med 5:47-78.
6. Christofidou-Solomidou M, Scherpereel A, Wiewrodt R, Ng K, Sweitzer T, Arguiri E, Shuvaev V, Solomides CC, Albelda SM, and Muzykantov VR (2003) PECAM-directed delivery of catalase to endothelium protects against pulmonary vascular oxidative stress. Am J Physiol 285:L283-L292.
7. Corvo ML, Boerman OC, Oyen WJ, Van Bloois L, Cruz ME, Crommelin DJ, and Storm G (1999) Intravenous administration of superoxide dismutase entrapped in long circulating liposomes: II. In vivo fate in a rat model of adjuvant arthritis. Biochim Biophys Acta 1419:325-334.
8. Day BJ, Shawen S, Liochev SI, and Crapo JD (1995) A metalloporphyrin superoxide dismutase mimetic protects against paraquat-induced endothelial cell injury, in vitro. J Pharmacol Exp Ther 275:1227-1232.
9. Duann P, Datta PK, Pan C, Blumberg JB, Sharma M, and Lianos EA (2006) Superoxide dismutase mimetic preserves the glomerular capillary permeability barrier to protein. J Pharmacol Exp Ther 316:1249-1254.
10. Freeman BA, Young SL, and Crapo JD (1983) Liposome-mediated augmentation of superoxide dismutase in endothelial cells prevents oxygen injury. J Biol Chem 258:12534-12542.
11. Fujita T, Nishikawa M, Tamaki C, Takakura Y, Hashida M, and Sezaki H (1992) Targeted delivery of human recombinant superoxide dismutase by chemical modification with mono- and polysaccharide derivatives. J Pharmacol Exp Ther 263: 971-978.
12. Gao B, Flores SC, Leff JA, Bose SK, and McCord JM (2003) Synthesis and anti-inflammatory activity of a chimeric recombinant superoxide dismutase: SOD2/3. Am J Physiol 284:L917-L925.
13. Giri SN and Misra HP (1984) Fate of superoxide dismutase in mice following oral route of administration. Med Biol 62:285-289.
14. Greenwald RA (1990) Superoxide dismutase and catalase as therapeutic agents for human diseases: a critical review. Free Radic Biol Med 8:201-209.
15. Guo AM, Arbab AS, Falck JR, Chen P, Edwards PA, Roman RJ, and Scicli AG (2007) Activation of vascular endothelial growth factor through reactive oxygen species mediates 20-hydroxyeicosatetraenoic acid-induced endothelial cell proliferation. J Pharmacol Exp Ther 321:18-27.
16. Houston M, Estevez A, Chumley P, Aslan M, Marklund S, Parks DA, and Freeman BA (1999) Binding of xanthine oxidase to vascular endothelium: kinetic characterization and oxidative impairment of nitric oxide-dependent signaling. J Biol Chem 274:4985-4994.
17. Igarashi R, Hoshino J, Ochiai A, Morizawa Y, and Mizushima Y (1994) Lecithinized superoxide dismutase enhances its pharmacologic potency by increasing its cell membrane affinity. J Pharmacol Exp Ther 271:1672-1677.
18. Jia L and Furchgott RF (1993) Inhibition by sulfhydryl compounds of vascular relaxation induced by nitric oxide and endothelium-derived relaxing factor. J Pharmacol Exp Ther 267:371-378.
19. Jiang J, Kurnikov I, Belikova NA, Xiao J, Zhao Q, Amoscato AA, Braslau R, Studer A, Fink MP, Greenberger JS, et al. (2007) Structural requirements for optimized delivery, inhibition of oxidative stress, and antiapoptotic activity of targeted nitroxides. J Pharmacol Exp Ther 320:1050-1060.
20. Kelley EE, Trostchansky A, Rubbo H, Freeman BA, Radi R, and Tarpey MM (2004) Binding of xanthine oxidase to glycosaminoglycans limits inhibition by oxypurinol. J Biol Chem 279:37231-37234.
21. Kinnula VL and Crapo JD (2003) Superoxide dismutases in the lung and human lung diseases. Am J Respir Crit Care Med 167:1600-1619.
22. Koo DD, Welsh KI, West NE, Channon KM, Penington AJ, Roake JA, Morris PJ, and Fuggle SV (2001) Endothelial cell protection against ischemia/reperfusion injury by lecithinized superoxide dismutase. Kidney Int 60:786-796.
23. Kozower BD, Christofidou-Solomidou M, Sweitzer TD, Muro S, Buerk DG, Solomides CC, Albelda SM, Patterson GA, and Muzykantov VR (2003) Immunotargeting of catalase to the pulmonary endothelium alleviates oxidative stress and reduces acute lung transplantation injury. Nat Biotechnol 21:392-398.
24. Li S, Tan Y, Viroonchatapan E, Pitt BR, and Huang L (2000) Targeted gene delivery to pulmonary endothelium by anti-PECAM antibody. Am J Physiol 278:L504-L511.
25. Loomis ED, Sullivan JC, Osmond DA, Pollock DM, and Pollock JS (2005) Endothelin mediates superoxide production and vasoconstriction through activation of NADPH oxidase and uncoupled nitric-oxide synthase in the rat aorta. J Pharmacol Exp Ther 315:1058-1064.
26. Lu M, Gong X, Lu Y, Guo J, Wang C, and Pan Y (2006) Molecular cloning and functional characterization of a cell-permeable superoxide dismutase targeted to lung adenocarcinoma cells: inhibition cell proliferation through the Akt/p27kip1 pathway. J Biol Chem 281:13620-13627.
27. McCord JM (2002) Superoxide dismutase in aging and disease: an overview. Methods Enzymol 349:331-341.
28. McCord JM and Fridovich I (1969) Superoxide dismutase: an enzymic function for erythrocuprein (hemocuprein). J Biol Chem 244:6049-6055.
29. Muro S, Cui X, Gajewski C, Murciano JC, Muzykantov VR, and Koval M (2003a) Slow intracellular trafficking of catalase nanoparticles targeted to ICAM-1 protects endothelial cells from oxidative stress. Am J Physiol 285:C1339-C1347.
30. Muro S, Dziubla T, Qiu W, Leferovich J, Cui X, Berk E, and Muzykantov VR (2006) Endothelial targeting of high-affinity multivalent polymer nanocarriers directed to intercellular adhesion molecule 1. J Pharmacol Exp Ther 317:1161-1169.
31. Muro S, Wiewrodt R, Thomas A, Koniaris L, Albelda SM, Muzykantov VR, and Koval M (2003b) A novel endocytic pathway induced by clustering endothelial ICAM-1 or PECAM-1. J Cell Sci 116:1599-1609.
32. Muzykantov VR (2001) Targeting of superoxide dismutase and catalase to vascular endothelium. J Control Release 71:1-21.
33. Muzykantov VR (2005) Biomedical aspects of targeted delivery of drugs to pulmonary endothelium. Expert Opin Drug Deliv 2:909-926.
34. Muzykantov VR, Christofidou-Solomidou M, Balyasnikova I, Harshaw DW, Schultz L, Fisher AB, and Albelda SM (1999) Streptavidin facilitates internalization and pulmonary targeting of an anti-endothelial cell antibody (platelet-endothelial cell adhesion molecule 1): a strategy for vascular immunotargeting of drugs. Proc Natl Acad Sci U S A 96:2379-2384.
35. Nebot C, Moutet M, Huet P, Xu JZ, Yadan JC, and Chaudiere J (1993) Spectrophotometric assay of superoxide dismutase activity based on the activated autoxidation of a tetracyclic catechol. Anal Biochem 214:442-451.
36. Nowak K, Weih S, Metzger R, Albrecht Ii RF, Post S, Hohenberger P, Gebhard MM, and Danilov SM (2007) Immunotargeting of catalase to lung endothelium via anti-ACE antibodies attenuates ischemia-reperfusion injury of the lung in vivo. Am J Physiol 293:L162-L169.
37. Scherpereel A, Rome JJ, Wiewrodt R, Watkins SC, Harshaw DW, Alder S, Christofidou-Solomidou M, Haut E, Murciano JC, Nakada M, et al. (2002) Plateletendothelial cell adhesion molecule-1-directed immunotargeting to cardiopulmonary vasculature. J Pharmacol Exp Ther 300:777-786.
38. Scherpereel A, Wiewrodt R, Christofidou-Solomidou M, Gervais R, Murciano JC, Albelda SM, and Muzykantov VR (2001) Cell-selective intracellular delivery of a foreign enzyme to endothelium in vivo using vascular immunotargeting. FASEB J 15:416-426.
39. Shuvaev VV, Dziubla T, Wiewrodt R, and Muzykantov VR (2004) Streptavidin-biotin crosslinking of therapeutic enzymes with carrier antibodies: nanoconjugates for protection against endothelial oxidative stress. Methods Mol Biol 283:3-20.
40. Tamura Y, Chi LG, Driscoll EM Jr, Hoff PT, Freeman BA, Gallagher KP, and Lucchesi BR (1988) Superoxide dismutase conjugated to polyethylene glycol provides sustained protection against myocardial ischemia/reperfusion injury in canine heart. Circ Res 63:944-959.
41. Terada LS, Guidot DM, Leff JA, Willingham IR, Hanley ME, Piermattei D, and Repine JE (1992) Hypoxia injures endothelial cells by increasing endogenous xanthine oxidase activity. Proc Natl Acad Sci U S A 89:3362-3366.